{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:00:38Z","timestamp":1790805638266,"version":"4.1.0"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000161","name":"National Institute of Standards and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014726","name":"National Institute for Innovation in Manufacturing Biopharmaceuticals","doi-asserted-by":"publisher","award":["70NANB17H002"],"award-info":[{"award-number":["70NANB17H002"]}],"id":[{"id":"10.13039\/100014726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014726","name":"National Institute for Innovation in Manufacturing Biopharmaceuticals","doi-asserted-by":"publisher","award":["Project Award Agreement"],"award-info":[{"award-number":["Project Award Agreement"]}],"id":[{"id":"10.13039\/100014726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tibtech.2026.09.005","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:37:18Z","timestamp":1790599038000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing mRNA therapeutics from design to delivery"],"prefix":"10.1016","author":[{"given":"Yongdan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5330-8784","authenticated-orcid":false,"given":"Seongkyu","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2026.09.005_bb0005","article-title":"Nonviral targeted mRNA delivery: principles, progresses, and challenges","volume":"6","author":"He","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2026.1800423","article-title":"In-process analytics for IVT mRNA manufacturing: from process understanding to advanced process control","volume":"14","author":"Kim","year":"2026","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11033-026-11455-0","article-title":"Process and analytical strategies for the safe production of mRNA vaccines and therapeutics","volume":"53","author":"Nowak","year":"2026","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102570","article-title":"Physicochemical and functional assessment of messenger RNA 5\u2032Cap-end impurities under forced degradation conditions","volume":"36","author":"Hutchinson","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/pharmaceutics14020430","article-title":"Stability modelling of mRNA vaccine quality based on temperature monitoring throughout the distribution Chain","volume":"14","author":"Kis","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0030","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1038\/s41467-021-26926-0","article-title":"A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems","volume":"12","author":"Packer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0035","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11095-026-04039-x","article-title":"Freezing-induced stress in mRNA-lipid nanoparticles during lyophilization: mechanistic insights from process and formulation studies","volume":"43","author":"Ruppl","year":"2026","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0040","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","article-title":"Addressing the cold reality of mRNA vaccine stability","volume":"110","author":"Crommelin","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0045","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/vaccines9091033","article-title":"Challenges of storage and stability of mRNA-based COVID-19 vaccines","volume":"9","author":"Uddin","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124514","article-title":"Design and lyophilization of mRNA-encapsulating lipid nanoparticles","volume":"662","author":"Wang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0055","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0060","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1038\/s41467-025-60959-z","article-title":"Cellular and biophysical barriers to lipid nanoparticle mediated delivery of RNA to the cytosol","volume":"16","author":"Johansson","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0065","article-title":"Beyond the endosomal bottleneck: understanding the efficiency of mRNA\/LNP delivery","volume":"34","author":"Liu","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202514370","article-title":"High-throughput in vivo screening using barcoded mRNA identifies lipid nanoparticles with extrahepatic tropism for in situ immunoengineering","volume":"38","author":"Hamilton","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/hum.2024.106","article-title":"Lipid nanoparticles for nucleic acid delivery beyond the liver","volume":"35","author":"Saber","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0080","article-title":"A combinatorial library of lipid nanoparticles for cell type-specific mRNA delivery","volume":"10","author":"Naidu","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41573-023-00827-x","article-title":"Tailor made: the art of therapeutic mRNA design","volume":"23","author":"Metkar","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0090","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1002\/bit.28806","article-title":"Quality by design approach to improve quality and decrease cost of in vitro transcription of mRNA using design of experiments","volume":"121","author":"Boman","year":"2024","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbt.2025.12.004","article-title":"Splint-free circular RNA synthesis via RNA secondary structure-guided ligation","volume":"91","author":"Kim","year":"2026","journal-title":"New Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1426129","article-title":"Understanding the impact of in vitro transcription byproducts and contaminants","volume":"11","author":"Lenk","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0105","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.3390\/ijms25073595","article-title":"mRNA-LNP COVID-19 vaccine lipids induce complement activation and production of proinflammatory cytokines: mechanisms, effects of complement inhibitors, and relevance to adverse reactions","volume":"25","author":"Bakos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Estap\u00e9 Senti","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4049\/immunohorizons.1900029","article-title":"Accelerated blood clearance of lipid nanoparticles entails a biphasic humoral response of B-1 followed by B-2 lymphocytes to distinct antigenic moieties","volume":"3","author":"Besin","year":"2019","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41541-023-00766-z","article-title":"Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0125","doi-asserted-by":"crossref","first-page":"17789","DOI":"10.1021\/acs.analchem.4c04162","article-title":"Exploring the impact of in vitro-transcribed mRNA impurities on cellular responses","volume":"96","author":"Camperi","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0130","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.tibtech.2022.03.012","article-title":"Quality by design for enabling RNA platform production processes","volume":"40","author":"Daniel","year":"2022","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0135","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.3390\/ijms25115718","article-title":"Analytical ultracentrifugation to assess the quality of LNP-mRNA therapeutics","volume":"25","author":"Guerrini","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0140","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/pharmaceutics12111095","article-title":"Manufacturing considerations for the development of lipid nanoparticles using microfluidics","volume":"12","author":"Roces","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.trsl.2021.11.009","article-title":"Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials","volume":"242","author":"Whitley","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7774\/cevr.2025.14.e40","article-title":"Advancements and challenges in next-generation mRNA vaccine manufacturing systems","volume":"14","author":"Seo","year":"2025","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0155","first-page":"8204","article-title":"Digital twin fundamentals of mRNA in vitro transcription in variable scale toward autonomous operation","volume":"9","author":"Hengelbrock","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126301","article-title":"End-to-end digital twin software for continuous mRNA manufacturing","volume":"686","author":"Shahab","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41586-022-05668-z","article-title":"mRNA ageing shapes the Cap2 methylome in mammalian mRNA","volume":"614","author":"Despic","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102456","article-title":"CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA","volume":"36","author":"Mandell","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0175","doi-asserted-by":"crossref","first-page":"10788","DOI":"10.1093\/nar\/gkae763","article-title":"Trinucleotide cap analogs with triphosphate chain modifications: synthesis, properties, and evaluation as mRNA capping reagents","volume":"52","author":"Warminski","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0180","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13059-024-03248-0","article-title":"Differences in 5\u2032untranslated regions highlight the importance of translational regulation of dosage sensitive genes","volume":"25","author":"Wieder","year":"2024","journal-title":"Genome Biol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0185","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2026.02.020","article-title":"Genome-wide detection of human 5\u2032 UTR variants that impact protein translation","volume":"113","author":"Chaldebas","year":"2026","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102485","article-title":"Enhancing mRNA translation efficiency by introducing sequence optimized AU-rich elements in 3\u2032 UTR via HuR anchorage","volume":"36","author":"Ma","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0195","doi-asserted-by":"crossref","DOI":"10.1093\/g3journal\/jkab404","article-title":"Massively parallel analysis of human 3\u2032 UTRs reveals that AU-rich element length and registration predict mRNA destabilization","volume":"12","author":"Siegel","year":"2022","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149254","article-title":"Optimizing mRNA translation efficiency through rational 5\u2032UTR and 3\u2032UTR combinatorial design","volume":"942","author":"Li","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0205","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1093\/nar\/gkae510","article-title":"The impact of mRNA poly(A) tail length on eukaryotic translation stages","volume":"52","author":"Biziaev","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0210","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf1412","article-title":"PolyA tail segmentation improves the stability of the template DNA and increases the translatability of in vitro transcribed mRNA","volume":"54","author":"Spiewla","year":"2026","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102453","article-title":"Use of polyadenosine tail mimetics to enhance mRNA expression from genes associated with haploinsufficiency disorders","volume":"36","author":"Torkzaban","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41587-024-02174-7","article-title":"Branched chemically modified poly(A) tails enhance the translation capacity of mRNA","volume":"43","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0225","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41541-025-01298-4","article-title":"A viral codon usage strategy enhances antigen production and protection in SFTSV mRNA vaccination","volume":"10","author":"Cha","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf386","article-title":"mRNA folding algorithms for structure and codon optimization","volume":"26","author":"Ward","year":"2025","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0235","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.1038\/s41467-025-64894-x","article-title":"Deep generative optimization of mRNA codon sequences for enhanced mRNA translation and therapeutic efficacy","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0240","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1101\/gr.278870.123","article-title":"CodonBERT large language model for mRNA vaccines","volume":"34","author":"Li","year":"2024","journal-title":"Genome Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0245","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbag047","article-title":"Multi-seed searching algorithm for integrated codon optimization of mRNA stability and translational efficiency in vaccine design","volume":"27","author":"Bo","year":"2026","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0250","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.omtn.2022.01.004","article-title":"Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages","volume":"27","author":"Moradian","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202521523","article-title":"\u201cMore\u201d artificial mRNAs: beyond the art of nature","volume":"13","author":"Cui","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/tcr.202200005","article-title":"Recent advances in modified cap analogs: synthesis, biochemical properties, and mRNA based vaccines","volume":"22","author":"Shanmugasundaram","year":"2022","journal-title":"Chem. Rec."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0265","article-title":"Cap 1 messenger RNA synthesis with co-transcriptional cleanCap\u00ae analog by in vitro transcription","volume":"1","author":"Henderson","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1261\/rna.080634.125","article-title":"Novel trinucleotide mRNA capping reagents: improved synthetic route and efficient cotranscriptional incorporation in mRNA","volume":"32","author":"Xu","year":"2026","journal-title":"RNA"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0275","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1021\/acs.accounts.3c00442","article-title":"Chemical modifications of mRNA ends for therapeutic applications","volume":"56","author":"Warminski","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0280","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1093\/jxb\/erae073","article-title":"Untranslated yet indispensable\u2014UTRs act as key regulators in the environmental control of gene expression","volume":"75","author":"Hardy","year":"2024","journal-title":"J. Exp. Bot."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0285","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1134\/S0006297924604659","article-title":"Selection of UTRs in mRNA-based gene therapy and vaccines","volume":"90","author":"Volkhin","year":"2025","journal-title":"Biochem. Mosc."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102648","article-title":"Evaluation of synthetic mRNA with selected UTR sequences and alternative poly(A) tail, in vitro and in vivo","volume":"36","author":"Medjmedj","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0295","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41434-026-00606-4","article-title":"CJ-1: an optimized mRNA platform with enhanced protein expression and minimal immunogenicity for therapeutic applications","volume":"33","author":"Kim","year":"2026","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0300","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1261\/rna.079046.121","article-title":"The interplay between translational efficiency, poly(A) tails, microRNAs, and neuronal activation","volume":"28","author":"Eisen","year":"2022","journal-title":"RNA"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0305","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41580-021-00417-y","article-title":"Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression","volume":"23","author":"Passmore","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0310","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.omtn.2022.10.003","article-title":"Cytidine-containing tails robustly enhance and prolong protein production of synthetic mRNA in cell and in vivo","volume":"30","author":"Li","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108015","article-title":"mRNA vaccine sequence and structure design and optimization: advances and challenges","volume":"301","author":"Jin","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0320","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02605-20","article-title":"Nonoptimal codon usage is critical for protein structure and function of the master general amino acid control regulator CPC-1","volume":"11","author":"Lyu","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0325","doi-asserted-by":"crossref","first-page":"W415","DOI":"10.1093\/nar\/gkaf410","article-title":"mRNAdesigner: an integrated web server for optimizing mRNA design and protein translation in eukaryotes","volume":"53","author":"Mo","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0330","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrm.2017.91","article-title":"Codon optimality, bias and usage in translation and mRNA decay","volume":"19","author":"Hanson","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0335","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0340","article-title":"In vitro transcribed mRNA immunogenicity induces chemokine-mediated lymphocyte recruitment and can be gradually tailored by uridine modification","volume":"11","author":"Drzeniek","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0345","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.omtn.2023.08.011","article-title":"Characterization of cooperative PS-oligo activation of human TLR9","volume":"33","author":"Pollak","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0350","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1021\/acs.chemrev.3c00611","article-title":"Chemically modified platforms for better RNA therapeutics","volume":"124","author":"Shi","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0355","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/v17040566","article-title":"Self-amplifying RNA: advantages and challenges of a versatile platform for vaccine development","volume":"17","author":"Vallet","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0360","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/v16040503","article-title":"Trans-amplifying RNA: a journey from alphavirus research to future vaccines","volume":"16","author":"Y\u0131ld\u0131z","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0365","article-title":"A novel self-amplifying mRNA with decreased cytotoxicity and enhanced protein expression by macrodomain mutations","volume":"11","author":"Gong","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113900","article-title":"Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across","volume":"176","author":"Minnaert","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0375","doi-asserted-by":"crossref","DOI":"10.1093\/narmme\/ugae004","article-title":"Self-amplifying RNAs generated with the modified nucleotides 5-methylcytidine and 5-methyluridine mediate strong expression and immunogenicity in vivo","volume":"1","author":"Azizi","year":"2024","journal-title":"NAR Mol. Med."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0380","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41576-024-00806-x","article-title":"The therapeutic potential of circular RNAs","volume":"26","author":"O\u2019leary","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0385","first-page":"7","article-title":"Unlocking the potential of engineered circular RNA therapeutics","volume":"4","author":"Zhen","year":"2026","journal-title":"Med. X"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0390","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/synbio4010004","article-title":"Synthetic strategies for linear and circular RNA","volume":"4","author":"Du","year":"2026","journal-title":"SynBio"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0395","article-title":"A flexible, efficient, and scalable platform to produce circular RNAs as new therapeutics","author":"Wei","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0400","first-page":"317","article-title":"Enhancing circular RNA translation efficiency through dual internal ribosome entry sites","volume":"15","author":"Sun","year":"2026","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0405","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41551-025-01344-5","article-title":"Small circular RNAs as vaccines for cancer immunotherapy","volume":"9","author":"Zhang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0410","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7150\/thno.104698","article-title":"Optimized circular RNA vaccines for superior cancer immunotherapy","volume":"15","author":"Yu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0415","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41587-025-02561-8","article-title":"Internal cap-initiated translation for efficient protein production from circular mRNA","volume":"44","author":"Fukuchi","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0420","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41551-024-01306-3","article-title":"Efficient circular RNA synthesis for potent rolling circle translation","volume":"9","author":"Du","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102333","article-title":"Quality by design for mRNA platform purification based on continuous oligo-dT chromatography","volume":"35","author":"Qu","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0430","article-title":"Multiple Gaussian process models based global sensitivity analysis and efficient optimization of in vitro mRNA transcription process","author":"Tao","year":"2024","journal-title":"arXiv"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0435","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/acs.biochem.4c00188","article-title":"High-throughput algorithmic optimization of in vitro transcription for SARS-CoV-2 mRNA vaccine production","volume":"63","author":"McMinn","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.70109","article-title":"Enhancing mRNA vaccine production: optimization of in vitro transcription for improved yield and purity","volume":"42","author":"Zhao","year":"2026","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2024.109412","article-title":"Maximizing the mRNA productivity for in vitro transcription by optimization of fed-batch strategy","volume":"210","author":"Guo","year":"2024","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102491","article-title":"Reverse-phase chromatography removes double-stranded RNA, fragments, and residual template to decrease immunogenicity and increase cell potency of mRNA and saRNA","volume":"36","author":"Kru\u0161i\u010d","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466610","article-title":"Single-step recovery of mRNA via multimodal chromatography to advance vaccine manufacturing","volume":"1766","author":"Rosa","year":"2026","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0460","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1186\/s12951-024-02919-1","article-title":"High-throughput synthesis and optimization of ionizable lipids through A3 coupling for efficient mRNA delivery","volume":"22","author":"Li","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501037","article-title":"Rational design of unsaturated, thioether ionizable lipids for enhanced in vivo mRNA delivery","volume":"14","author":"Samaridou","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0470","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1039\/D5MD00115C","article-title":"New ionizable lipids for non-viral mRNA delivery with secondary amine cyclic ether head groups","volume":"16","author":"Dane","year":"2025","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0475","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1021\/acsnano.4c18636","article-title":"Ionizable lipids with optimized linkers enable lung-specific, lipid nanoparticle-mediated mRNA delivery for treatment of metastatic lung tumors","volume":"19","author":"Naidu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0480","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1021\/acsbiomaterials.5c00463","article-title":"Structure-activity relationship of ionizable lipids for siRNA and mRNA lipid nanoparticle design","volume":"11","author":"Lee","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0485","article-title":"Rational design of lipid nanoparticles for enhanced mRNA vaccine delivery via machine learning","volume":"21","author":"Bae","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0490","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41565-021-01030-y","article-title":"Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles","volume":"17","author":"Hatit","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0495","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41587-025-02711-y","article-title":"Lipid nanoparticle screening in nonhuman primates with minimal loss of life","volume":"44","author":"Zenhausern","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0500","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3390\/nano12142446","article-title":"In cellulo and in vivo comparison of cholesterol, beta-sitosterol and dioleylphosphatidylethanolamine for lipid nanoparticle formulation of mRNA","volume":"12","author":"Medjmedj","year":"2022","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0505","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.1021\/acs.nanolett.4c01458","article-title":"Helper lipid-enhanced mRNA delivery for treating metabolic dysfunction-associated fatty liver disease","volume":"24","author":"Guo","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0510","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300123","article-title":"Exploration of mRNA nanoparticles based on DOTAP through optimization of the helper lipids","volume":"18","author":"Ma","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0515","doi-asserted-by":"crossref","first-page":"41836","DOI":"10.1021\/acsnano.5c15903","article-title":"Customizable mRNA lipid nanoparticles for transfection of primary human T cells","volume":"19","author":"VanKeulen-Miller","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0520","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0525","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/pharmaceutics17080950","article-title":"Formulation-driven optimization of PEG-lipid content in lipid nanoparticles for enhanced mRNA delivery in vitro and in vivo","volume":"17","author":"Liu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0530","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1021\/acsnano.4c09399","article-title":"Deciphering the role of pegylation on the lipid nanoparticle-mediated mRNA delivery to the liver","volume":"19","author":"Gao","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0535","doi-asserted-by":"crossref","first-page":"11329","DOI":"10.1039\/D5NR00433K","article-title":"PEGylated lipid screening, composition optimization, and structure-activity relationship determination for lipid nanoparticle-mediated mRNA delivery","volume":"17","author":"Liu","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0540","first-page":"86","article-title":"Engineering LNPs with polysarcosine lipids for mRNA delivery","volume":"37","author":"Kang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0545","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1002\/pol.20240154","article-title":"Influence of structural variations in polysarcosine functionalized lipids on lipid nanoparticle-mediated mRNA delivery","volume":"62","author":"Tan","year":"2024","journal-title":"J. Polym. Sci."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2024.1383038","article-title":"Poly(2-methyl-2-oxazoline) as a polyethylene glycol alternative for lipid nanoparticle formulation","volume":"4","author":"van Zyl","year":"2024","journal-title":"Front. Drug Deliv."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0555","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1021\/acs.biomac.4c00651","article-title":"Tailored monoacyl poly(2-oxazoline)- and poly(2-oxazine)-lipids as PEG-lipid alternatives for stabilization and delivery of mRNA-lipid nanoparticles","volume":"25","author":"He","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0560","doi-asserted-by":"crossref","unstructured":"Ensminger, Y. et al. Polyglycerol-based lipids: a next-generation alternative to PEG in lipid nanoparticles for advanced drug delivery systems. Macromol. Rapid Commun. 47, e00428","DOI":"10.1002\/marc.202500428"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0565","article-title":"Potent liver-tropic mRNA lipid nanoparticles: ApoE-mediated delivery through a low-density lipoprotein receptor independent uptake mechanism","volume":"38","author":"Sarode","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0570","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0575","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41563-025-02331-6","article-title":"Peptide codes for organ-selective mRNA delivery","volume":"25","author":"Chang","year":"2026","journal-title":"Nat. Mater."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0580","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41565-024-01747-6","article-title":"Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery","volume":"20","author":"Xue","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0585","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/psc.3053","article-title":"Modulation of immunogenicity of poly(sarcosine) displayed on various nanoparticle surfaces due to different physical properties","volume":"23","author":"Kim","year":"2017","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.466387","article-title":"Developing a high-throughput capillary gel electrophoresis workflow for mRNA integrity and poly(A) tail analysis","volume":"1761","author":"Su","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115692","article-title":"A single-nucleotide resolution capillary gel electrophoresis workflow for poly(A) tail characterization in the development of mRNA therapeutics and vaccines","volume":"236","author":"Di Grandi","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0600","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3390\/pharmaceutics16091227","article-title":"Development of biolayer interferometry (BLI)-based double-stranded RNA detection method with application in mRNA-based therapeutics and vaccines","volume":"16","author":"Silas","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0605","doi-asserted-by":"crossref","first-page":"18","DOI":"10.56530\/lcgc.eu.fd3584v4","article-title":"Multi-attribute monitoring of therapeutic mRNA by liquid chromatography\u2013mass spectrometry","volume":"36","author":"Menneteau","year":"2023","journal-title":"LCGC Eur."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.465724","article-title":"Characterisation and analysis of mRNA critical quality attributes using liquid chromatography based methods","volume":"1745","author":"Webb","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.164284","article-title":"Oscillatory microfluidic bioreactor for accelerated mRNA synthesis and enhanced protein expression","volume":"517","author":"Sharma","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0620","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1021\/acs.nanolett.3c01699","article-title":"Microfluidic bioreactor with fibrous micromixers for in vitro mRNA transcription","volume":"23","author":"Choi","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.memsci.2025.123730","article-title":"Single-pass tangential flow filtration (SPTFF) for continuous mRNA concentration and purification","volume":"719","author":"Javidanbardan","year":"2025","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0630","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/pharmaceutics13091371","article-title":"Pharma 4.0 continuous mRNA drug products manufacturing","volume":"13","author":"Ouranidis","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0635","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.3390\/pr9111967","article-title":"Digital twins for continuous mRNA production","volume":"9","author":"Helgers","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0640","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","article-title":"COVID-19 mRNA vaccines: platforms and current developments","volume":"30","author":"Szab\u00f3","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0645","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"mRNA vaccines manufacturing: challenges and bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0650","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/vaccines10010049","article-title":"Biophysical characterization of viral and lipid-based vectors for vaccines and therapeutics with light scattering and calorimetric techniques","volume":"10","author":"Markova","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0655","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/elps.8123","article-title":"A comprehensive evaluation of analytical method parameters critical to the reliable assessment of therapeutic mRNA integrity by capillary gel electrophoresis","volume":"46","author":"Tran","year":"2025","journal-title":"Electrophoresis"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0660","article-title":"RP-HPLC-CAD method for the rapid analysis of lipids used in lipid nanoparticles derived from dual centrifugation","volume":"7","author":"Bender","year":"2024","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0665","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/vaccines11071224","article-title":"Development and characterization of an in vitro cell-based assay to predict potency of mRNA\u2013LNP-based vaccines","volume":"11","author":"Patel","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0670","doi-asserted-by":"crossref","first-page":"33058","DOI":"10.1021\/acsnano.4c08490","article-title":"Distinct inflammatory programs underlie the intramuscular lipid nanoparticle response","volume":"18","author":"Dowell","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0675","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1021\/acs.analchem.9b01664","article-title":"Oligonucleotide sequence mapping of large therapeutic mRNAs via parallel ribonuclease digestions and LC-MS\/MS","volume":"91","author":"Jiang","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0680","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1021\/acs.analchem.5c06819","article-title":"Assessing mRNA and sgRNA quality for cell and gene therapy applications using nanopore direct RNA sequencing","volume":"98","author":"Chatla","year":"2026","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0685","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.4155\/bio-2021-0096","article-title":"Rapid development of analytical methods for evaluating pandemic vaccines: a covid-19 perspective","volume":"13","author":"Baldwin","year":"2021","journal-title":"Bioanalysis"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0690","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/14760584.2024.2354251","article-title":"Research progress on the quality control of mRNA vaccines","volume":"23","author":"Hu","year":"2024","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0695","first-page":"12758","article-title":"Impact of lipid tail length on the organ selectivity of mRNA-lipid nanoparticles","volume":"24","author":"Hashiba","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0700","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41467-023-37465-1","article-title":"GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy","volume":"14","author":"Kasiewicz","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2026.126679","article-title":"Combination of HGF\/IL-22 mRNAs delivered by GalNAc-lipid nanoparticles to treat acute liver injury","volume":"693","author":"Luo","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0710","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1021\/acs.bioconjchem.5c00282","article-title":"Mannose-conjugated cholesterol containing lipid nanoparticles for active targeted mRNA delivery to liver sinusoidal endothelial and Kupffer cells","volume":"36","author":"Kim","year":"2025","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0715","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1021\/acs.biomac.5c02390","article-title":"Selective mRNA delivery to activated macrophages via hyaluronic acid-functionalized lipid nanoparticles with optimized pegylation","volume":"27","author":"Cao","year":"2026","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0720","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41565-025-01954-9","article-title":"A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles","volume":"20","author":"Chen","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102520","article-title":"Targeted mRNA delivery with bispecific antibodies that tether LNPs to cell surface markers","volume":"36","author":"Dietmair","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0730","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0735","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2026.2637266","article-title":"Lipid nanoparticles with aptamers enable targeted mRNA delivery to CD4+ T cells","volume":"33","author":"Shah","year":"2026","journal-title":"Drug Deliv."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0740","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1039\/C4TB01316F","article-title":"The liposome-protein Corona in mice and humans and its implications for in vivo delivery","volume":"2","author":"Caracciolo","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0745","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1021\/acs.bioconjchem.0c00295","article-title":"Combinatorial library of cyclic benzylidene acetal-containing pH-responsive lipidoid nanoparticles for intracellular mRNA delivery","volume":"31","author":"Li","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0750","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s13346-025-02040-2","article-title":"Stimuli-responsive nanocarriers for targeted mRNA therapeutics: a paradigm shift in mRNA delivery for biomedical applications","volume":"16","author":"Yadav","year":"2026","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0755","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2528477123","article-title":"A human cardiomyocyte screen identifies optimized lipid nanoparticles for in vivo cardiac gene editing","volume":"123","author":"Sun","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0760","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/vaccines13020178","article-title":"In situ tumor vaccination using lipid nanoparticles to deliver interferon-\u03b2 mRNA cargo","volume":"13","author":"Kimura","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0765","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1021\/acsami.5c21156","article-title":"Magnetic lipid nanoparticles for targeted mRNA delivery and enhanced organ-specific expression","volume":"18","author":"Jin","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0770","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12951-024-02634-x","article-title":"Exosome for mRNA delivery: strategies and therapeutic applications","volume":"22","author":"Iqbal","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0775","article-title":"Novel endogenous engineering platform for robust loading and delivery of functional mRNA by extracellular vesicles","volume":"11","author":"Zickler","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0780","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.ymthe.2026.01.037","article-title":"Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression","volume":"34","author":"Zeng","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0785","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99263","article-title":"Generation and testing of clinical-grade exosomes for pancreatic cancer","volume":"3","author":"Mendt","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0790","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1021\/acsnano.5c16068","article-title":"A dual-fusogenic virus-like vector enables direct cytosolic delivery of mRNA vaccines to dendritic cells","volume":"20","author":"Chen","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0795","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1038\/s41467-025-64181-9","article-title":"Engineering a streamlined virus-like particle for programmable tissue-specific gene delivery","volume":"16","author":"Han","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114385","article-title":"Design of messenger RNA vaccines based on lipid-polymer hybrid nanoparticles","volume":"388","author":"Baghel","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0805","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1021\/acs.accounts.5c00874","article-title":"Lipid-polymer hybrid nanoparticles (LPHNPs) for RNA delivery","volume":"59","author":"Saiding","year":"2026","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110946","article-title":"Scalable purification enables high-quality virus-like particles for therapeutic translation","volume":"301","author":"Ho\u0142ubowicz","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0820","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.omtn.2022.09.017","article-title":"Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates","volume":"30","author":"Suzuki","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0825","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acsnano.2c10501","article-title":"Ready-to-use-type lyophilized lipid nanoparticle formulation for the postencapsulation of messenger RNA","volume":"17","author":"Tanaka","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0830","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/biologics5040035","article-title":"Advancements in pharmaceutical lyophilization: integrating QbD, AI, and novel formulation strategies for next-generation biopharmaceuticals","volume":"5","author":"Atre","year":"2025","journal-title":"Biologics"},{"key":"10.1016\/j.tibtech.2026.09.005_bb0835","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.tibtech.2026.09.005_bb0840","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1021\/acsnano.4c12965","article-title":"Robust, scalable microfluidic manufacturing of RNA-lipid nanoparticles using immobilized antifouling lubricant coating","volume":"19","author":"Hwang","year":"2024","journal-title":"ACS Nano"}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779926003756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779926003756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:34:27Z","timestamp":1790804067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779926003756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":168,"alternative-id":["S0167779926003756"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.09.005","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing mRNA therapeutics from design to delivery","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2026.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}